C795-0140 Screening compound: N-[5-(4-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide

C795-0140 Screening compound: N-[5-(4-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide
C795-0140 Screening compound: N-[5-(4-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C795-0140
N-[5-(4-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C795-0140

Molecular Formula

C17H19N5O3S (C17 H19 N5 O3 S)

Compound Name

N-[5-(4-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide

IUPAC name

N-[5-(4-methylpiperidin-1-yl)-134-thiadiazol-2-yl]-2-(2-oxo-23-dihydro-13-benzoxazol-3-yl)acetamide

SMILES

CC(CC1)CCN1c1nnc(NC(CN(c(cccc2)c2O2)C2=O)=O)s1

InChI

InChI=1S/C17H19N5O3S/c1-11-6-8-21(9-7-11)16-20-19-15(26-16)18-14(23)10-22-12-4-2-3-5-13(12)25-17(22)24/h2-5,11H,6-10H2,1H3,(H,18,19,23)

InChI Key

NBXVDFXOBDFHKY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14796743

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

373.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.116

Distribution Coefficient, logD

3.115

Water Solubility, LogSw

-3.57

Polar Surface Area

73.029

Acid Dissociation Constant (pKa)

10.61

Base Dissociation Constant (pKb)

0.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.20

C795-0140 in Drug Discovery

Included in Screening Libraries

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C795-0140 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C795-0140?
Check Price and Availability of C795-0140, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C795-0140 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C795-0140
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C795-0140
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C795-0140 available by request